# A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma

> **NCT05127811** · PHASE1 · TERMINATED · sponsor: **Zentera Therapeutics HK Limited** · enrollment: 8 (actual)

## Conditions studied

- Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** ZN-d5

## Key facts

- **NCT ID:** NCT05127811
- **Lead sponsor:** Zentera Therapeutics HK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-21
- **Primary completion:** 2023-05-26
- **Final completion:** 2023-05-26
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05127811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05127811, "A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05127811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*